文献速递腹部MR

钆塞酸二钠增强MRI定性与定量特征及分类回归树分析鉴别局灶性结节性增生与肝细胞腺瘤

Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis.
PubMed 文献 · Abdom Radiol (NY) · 2022-12-17

肝胆期T1信号强度定性分析敏感度91.9%、特异度90.1%、准确率90.9%;定量分析肝胆期相对信号增强率(RSER)阈值0.723时敏感度92.6%、特异度89.4%。基于5个定性特征的CART模型准确率94.4%(95%CI 90.0-98.9%)。

要点

  • 肝胆期T1信号强度是鉴别FNH与HCA的最有效定性特征,准确率90.9%。
  • 肝胆期RSER阈值0.723时鉴别效能最高,敏感度92.6%、特异度89.4%。
  • 基于5个定性特征的CART模型准确率达94.4%,可辅助决策。

关键影像表现/征象

  • 肝胆期T1信号强度定性分类整体效能最高,敏感度91.9%、特异度90.1%、准确率90.9%。
  • 定量分析中肝胆期RSER鉴别FNH与HCA的效能最高,阈值0.723时敏感度92.6%、特异度89.4%。

诊断标准与关键数值

  • 定性特征:肝胆期T1信号强度,敏感度91.9%、特异度90.1%、准确率90.9%。
  • 定量特征:肝胆期RSER阈值0.723,敏感度92.6%、特异度89.4%。
  • CART模型基于5个定性特征,准确率94.4%(95%CI 90.0-98.9%)。

临床应用与阅片要点

  • 阅片时应重点评估肝胆期T1信号强度,作为鉴别FNH与HCA的首选定性特征。
  • 可计算肝胆期RSER,以0.723为阈值辅助区分FNH与HCA。
  • CART模型基于5个定性特征,可作为结构化报告中的决策参考。

局限性

  • 回顾性研究设计。
  • 单中心研究。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

PURPOSE: To assess qualitative and quantitative analysis of gadoxetate disodium-enhanced hepatobiliary phase MR imaging (MRI) and assess the performance of classification and regression tree analysis for the differentiation of focal nodular hyperplasia (FNH) and hepatocellular adenoma (HCA).

MATERIALS AND METHODS: This retrospective study was approved by our local ethics committee. One hundred seventy patients suspected of having FNH or HCA underwent gadoxetate disodium-enhanced MRI. The reference standard was either pathology or follow-up imaging. Two readers reviewed images to identify qualitative imaging features and measure signal intensity on unenhanced, dynamic, and hepatobiliary phase images. For quantitative analysis, contrast enhancement ratio (CER), lesion-to-liver contrast (LLC), signal intensity ratio (SIR), and relative signal enhancement ratio (RSER) were calculated. A classification and regression tree (CART) analysis was developed.

RESULTS: Eighty-five patients met the inclusion criteria, with a total of 97 FNHs and 43 HCAs. For qualitative analysis, the T1 signal intensity on the hepatobiliary phase provided the highest overall classification performance (91.9% sensitivity, 90.1% specificity, and 90.9% accuracy). For quantitative analysis, RSER in the hepatobiliary phase with a threshold of 0.723 provided the highest classification performance (92.6% sensitivity and 89.4% specificity) to differentiate FNHs from HCAs. A CART model based on five qualitative imaging features provided an accuracy of 94.4% (95% confidence interval 90.0-98.9%).

CONCLUSION: Gadoxetate disodium-enhanced hepatobiliary phase provides high diagnostic performance as demonstrated in quantitative and qualitative analysis in differentiation of FNH and HCA, supported by a CART decision model.

来源:Abdom Radiol (NY),查看原文。版权归原作者所有。

引用

  1. Alamri, Cerny, Al Shaikh, et al. Differentiation of focal nodular hyperplasia and hepatocellular adenoma using qualitative and quantitative imaging features and classification and regression tree analysis. Abdom Radiol (NY). 2022. PMID: 36528729. doi:10.1007/s00261-022-03766-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。